Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Rank in Stocks
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Share Price
$20.91
Market Cap
$7.57B
Change (1 day)
-8.26%
Change (1 year)
41.25%
Country
CN
Trade Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Category
Healthcare
Number of shares outstanding for Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Number of shares outstanding as of June 2026: 356.25M
According to Asymchem Laboratories (Tianjin) Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 356.25M. At the end of December 2024 the company had 352.77M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Asymchem Laboratories (Tianjin) Co., Ltd. (002821) from 2011 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 356.25M | -0.60% |
| 2025 | 358.41M | 1.60% |
| 2024 | 352.77M | -2.67% |
| 2023 | 362.43M | -0.98% |
| 2022 | 366.03M | 7.77% |
| 2021 | 339.64M | 4.15% |
| 2020 | 326.11M | 1.78% |
| 2019 | 320.42M | 0.46% |
| 2018 | 318.94M | 0.80% |
| 2017 | 316.43M | 23.41% |
| 2016 | 256.40M | 1.98% |
| 2015 | 251.42M | -0.31% |
| 2014 | 252.21M | 0.04% |
| 2013 | 252.10M | 0.13% |
| 2012 | 251.78M | 0.41% |
| 2011 | 250.74M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -28.73% |
US
|
|
| 396.00M | 11.16% |
US
|
|
| 478.91M | 34.43% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -82.54% |
NL
|
